Statement in response to delay in key policies on junk food advertising and promotions

May 18, 2022

This week, the government announced that it will be delaying two key policies to tackle obesity in the UK. These are:

  • Banning multi-buy deals of food and drink, which are high in fat, sugar and salt, which has been delayed until October 2023.
  • Restricting junk food tv advertisements before 9pm watershed, which has been delayed until January 2024.

In response to this decision, we have supported an open letter to Boris Johnson from Jamie Oliver and our chief executive, Pamela Healy, has issued the following statement.

“We are extremely disappointed with this shocking decision by the government which will put millions of lives at risk.  A record number of people were admitted to hospital with obesity-related conditions in 2020 and without action the situation will only get worse, putting additional pressure on the NHS.

“Being overweight is the main risk factor for non-alcohol related fatty liver disease. The condition is set to overtake alcohol as the main reason for liver transplants in the next few years. Overweight children are at a much higher risk of developing this condition in  later life which can lead to cirrhosis and cancer.

“As a nation, we have the highest obesity levels in Europe and we are consuming more calories than we should every day.  The government must urgently tackle the accessibility and abundance of unhealthy food which is significantly cheaper than healthy alternatives.  This has to start with reinstating plans to restrict multibuy deals and advertising of unhealthy foods with immediate effect.”

More news

Liver UK helps shape new European recommendations on liver cancer surveillance

Liver UK helps shape new European recommendations on liver cancer surveillance

A major new paper published in The Lancet Regional Health – Europe has highlighted the challenges of detecting liver cancer earlier across Europe and sets out practical lessons from countries around the world to improve surveillance ...
The LIVERAGE research studies

The LIVERAGE research studies

The LIVERAGE and LIVERAGE Cirrhosis studies are large clinical research studies for adults living with MASLD, a type of fatty liver disease. These studies focus on people with MASH, a more advanced form of MASLD.  The studies include ...
Three in four people first diagnosed with liver disease during emergency hospital admission, major new study finds

Three in four people first diagnosed with liver disease during emergency hospital admission, major new study finds

Three in four people are first diagnosed with liver disease during an emergency hospital admission, according to a major national study published in the European Journal of Internal Medicine .  The study found that almost 60% of these ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.